EICHORCondition: Crohn's Disease · Sponsor: Abbott
The objectives were: (1) To demonstrate the efficacy of adalimumab in the maintenance of clinical remission up to 56 weeks in participants with Crohn's disease who participated in NCT00055523; (2) To delineate the safety of adalimumab when administered to participants with Crohn's disease up to 56 weeks.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Inclusion: * Patient must have successfully completed the induction study NCT00055523 * Diagnosis of Crohn's disease * Willing and able to give informed consent Exclusion: * Diagnosis of ulcerative colitis * Pregnancy or breastfeeding * Previous use of infliximab or other anti-TNF antagonists * Previous history of active tuberculosis or listeria infection * Previous history of cancer other than successfully treated skin cancer
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| Gastroenterology Associates of the East Bay | Berkeley, California, United States | — |
| Long Beach Gastroenterology Assoc. | Long Beach, California, United States | — |
| Sharp Rees-Stealy Medical Group | San Diego, California, United States | — |
| Gastroenterology Assoc. of Fairfield Co. | Bridgeport, Connecticut, United States | — |
| Cleveland Clinic Florida | Weston, Florida, United States | — |
| Wake Research Associates | Weston, Florida, United States | — |
| Shafran Gastroenterology Center | Winter Park, Florida, United States | — |
| Atlanta Gastroenterology Assoc. | Atlanta, Georgia, United States | — |
| Southeastern Digestive & Liver Disease | Savannah, Georgia, United States | — |
| Northwest Gastroenterologists, S.C. | Arlington Heights, Illinois, United States | — |
| University of Chicago | Chicago, Illinois, United States | — |
| Drug Research Services, Inc. | Metairie, Louisiana, United States | — |
+ 31 more locations — full list on the registry record.
This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT00055497